Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy clinical trial (NCT02204098). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the Mammaglobin-A vaccine work to help my immune system?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy clinical trial (NCT02204098). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like, and how often will I need to come in for visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy clinical trial (NCT02204098). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any side effects I should be aware of from the vaccine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy clinical trial (NCT02204098). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy clinical trial (NCT02204098). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or complications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy clinical trial (NCT02204098). Contact the study team or your healthcare provider for specific answers.

What this study is about